Association between high-sensitivity C-reactive protein and metabolic syndrome: systematic review and meta-analysis

Authors:

Abstract
Background: Metabolic syndrome (MetS) is a cluster of cardiometabolic abnormalities associated with chronic low-grade systemic inflammation. High-sensitivity C-reactive protein (hs-CRP) is a sensitive biomarker of inflammation and has been proposed as a potential indicator of MetS. However, the magnitude of the association between hs-CRP and MetS remains inconsistent across populations. This systematic review and meta-analysis aimed to quantify the difference in hs-CRP levels between individuals with and without MetS. Methods: A systematic search of PubMed/MEDLINE, EMBASE, Scopus, Web of Science, Cochrane Library, Epistemonikos, and gray literature sources was conducted. Eligible observational studies reporting mean and standard deviation of hs-CRP among participants with and without MetS were included. Data were pooled using a random-effects model, and standardized mean differences (SMDs) with 95% confidence intervals (CIs) were calculated. Subgroup analyses were performed according to geographic region, study design, study setting, fasting status, hs-CRP assay type, and MetS diagnostic criteria. Results: Twenty-eight studies involving 71,882 participants (23,945 MetS cases and 47,937 controls) were included. Overall, hs-CRP levels were significantly higher among individuals with MetS than among healthy controls (SMD = 0.95, 95% CI: 0.81–1.10; p < 0.001). Significant heterogeneity was observed across studies (I² = 99.49%, p < 0.001). Subgroup analyses demonstrated higher effect estimates in Europe (SMD = 2.84) and Africa (SMD = 2.63) compared with Asia and the Middle East. The association remained significant across study designs, settings, assay methods, and MetS diagnostic criteria. Conclusions: People with metabolic syndrome had greater levels of hs-CRP than people without the condition. However, causal interpretation is constrained by the observational nature of the available data and significant between-study heterogeneity. To ascertain the temporal connection between hs-CRP and metabolic syndrome, prospective longitudinal studies are required.